11，Sandler M. Is the lung a `Target Organ'in diabetes mellitus? Arch Inter Med, 1990,150:1381
22，Stroje K, Ziora D, Snoczynski JW, et al. Pulmonary complications of type-I(insulin-dependent)diabetic patients. Diabetologia,1992,35:1173
33，Primhak RA, Whincup G, Tsanakas JN, et al. Reduced vital capacity in insulin-dependent diabetes. Diabetes, 1987,36:324
44，Mohsenin V, Latifpour J. Respiratory burst in alveolar macrophages of diabetic rats. J Appl Physiol, 1990,6:2384
55，Edmondson EB,Sanford JB. The Klebsiella-Enterobacter Serratia group, A clinical and bacteriological evaluation. Medicine ,1967,46:323
66， Centry LO, Rodriguez Gomez G, Kohler RB,et al. Parenteral followed by oral ofloxacin for nosocomial pneumonia and community acquired pneumonia requiring hospitalization. Am Rev Respir Dis, 1992,145:31
5Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease,asthma,and risk of type 2 diabetes in women[ J]. Diabetes Care, 2004,27 ( 10) :2478 - 2484.
6Sevenoaks M J, Stockley RA. Chronic obstructive pulmonary disease, inflammation and co-morbidity--a common nflammatory phenotype? [ J]. Respir Res ,2006,7:70.
7Straface E, Matarrese P, Gambardella L, et al. N-Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease [ J ]. Biochem Biophys Res Commun, 2000,279 (2) :552 -556.
8Strsface E, Rivabene R, Masella R, et al. Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes:protective effects of N-acetylcysteine [ J ]. Biochem Biophys Res Commun, 2002,290(5) :1393 - 1398.
9Rodriguez Y, Christophe AB. Long-chain omega6 polyunsaturated fatty acids in erythrocyte phospholipids are associated with insulin resistance in non-obese type 2 diabetics [ J]. Clin Chim Acta,2005, 354( 1 -2) :195 - 199.
10Baker EH, Janaway CH, Philips B J, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with aeute exacerbations of chronic obstructive pulmonary disease[ J]. Thorax, 2006,61 (4) :284 -289.
